89 related articles for article (PubMed ID: 9718467)
1. Telomerase activity in body cavity fluid and peritoneal washings in uterine and ovarian cancer.
Murakami J; Nagai N; Ohama K
J Int Med Res; 1998; 26(3):129-39. PubMed ID: 9718467
[TBL] [Abstract][Full Text] [Related]
2. Applications of the telomerase assay in peritoneal washing fluids.
Tseng CJ; Jain S; Hou HC; Liu W; Pao CC; Lin CT; Horng SG; Soong YK; Hsueh S
Gynecol Oncol; 2001 Jun; 81(3):420-3. PubMed ID: 11371132
[TBL] [Abstract][Full Text] [Related]
3. Detection of ovarian cancer cells: comparison of a telomerase assay and cytologic examination.
Duggan BD; Wan M; Yu MC; Roman LD; Muderspach LI; Delgadillo E; Li WZ; Martin SE; Dubeau L
J Natl Cancer Inst; 1998 Feb; 90(3):238-42. PubMed ID: 9462682
[TBL] [Abstract][Full Text] [Related]
4. Detection of malignant effusions: comparison of a telomerase assay and cytologic examination.
Braunschweig R; Yan P; Guilleret I; Delacretaz F; Bosman FT; Mihaescu A; Benhattar J
Diagn Cytopathol; 2001 Mar; 24(3):174-80. PubMed ID: 11241900
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of telomerase activity in gastric carcinoma and peritoneal dissemination.
Hu X; Wu H; Zhang S; Yuan H; Cao L
J Int Med Res; 2009; 37(4):1127-38. PubMed ID: 19761695
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of telomerase activity and cytologic diagnosis in malignant ascites.
Park ES; Lee J; Kang SY; Lee EJ; Lee MH; Yoon N; Oh YL; Kim KM
Anal Quant Cytopathol Histpathol; 2013 Jun; 35(3):146-51. PubMed ID: 24344501
[TBL] [Abstract][Full Text] [Related]
7. Telomerase assay for differentiating between malignancy-related and nonmalignant ascites.
Tangkijvanich P; Tresukosol D; Sampatanukul P; Sakdikul S; Voravud N; Mahachai V; Mutirangura A
Clin Cancer Res; 1999 Sep; 5(9):2470-5. PubMed ID: 10499621
[TBL] [Abstract][Full Text] [Related]
8. Detection of the human telomerase RNA component by in situ hybridization in cells from body fluids.
Nieh S; Chen SF; Fu E; Jan CI; Lee WH
Acta Cytol; 2005; 49(1):31-7. PubMed ID: 15717752
[TBL] [Abstract][Full Text] [Related]
9. Detection of telomerase activity in peritoneal lavage fluid from patients with gastric cancer using immunomagnetic beads.
Mori N; Oka M; Hazama S; Iizuka N; Yamamoto K; Yoshino S; Tangoku A; Noma T; Hirose K
Br J Cancer; 2000 Oct; 83(8):1026-32. PubMed ID: 10993650
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of detecting telomerase activity in ascites cells from patients with ovarian carcinoma].
Jin S; Zhang W; Wang H; Liu Y; Gao F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Dec; 21(6):455-9. PubMed ID: 12567493
[TBL] [Abstract][Full Text] [Related]
11. Telomerase activity in benign and malignant cytologic fluids.
Mu XC; Brien TP; Ross JS; Lowry CV; McKenna BJ
Cancer; 1999 Apr; 87(2):93-9. PubMed ID: 10227600
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of telomerase activity in peritoneal lavage fluid from patients with gastric cancer and its relationship with cellular proliferation.
Da MX; Wu XT; Guo TK; Zhao ZG; Luo T; Qian K; Zhang MM; Wang J
World J Gastroenterol; 2007 Jun; 13(22):3122-7. PubMed ID: 17589931
[TBL] [Abstract][Full Text] [Related]
13. Telomerase activity and hTERT mRNA expression in body fluids.
Yamamoto Y; Hirakawa E
Diagn Cytopathol; 2005 Mar; 32(3):167-70. PubMed ID: 15690332
[TBL] [Abstract][Full Text] [Related]
14. Cytological diagnosis and telomerase activity of cells in effusions of body cavities.
Toshima S; Arai T; Yasuda Y; Takaya T; Ito Y; Hayakawa K; Shibuya C; Yoshimi N; Shibayama M; Kashiki Y
Oncol Rep; 1999; 6(1):199-203. PubMed ID: 9864428
[TBL] [Abstract][Full Text] [Related]
15. Detection of residual subclinical ovarian carcinoma after completion of adjuvant chemotherapy.
Nouriani M; Bahador A; Berek JS; Cheng JP; Chi DS; Cliby WA; Del Priore G; Dodson MK; Duggan BD; Gershenson DM; Lentz SE; Penson RT; Robinson WR; Rodriguez M; Roman LD; Yu MC; Zempolich K; Dubeau L
Clin Cancer Res; 2004 Apr; 10(8):2681-6. PubMed ID: 15102671
[TBL] [Abstract][Full Text] [Related]
16. Study of telomerase activity in pleural lavage fluid specimens in patients with non-small-cell lung cancer and its clinical significance.
Li W; Ni Y; Tu Z; Wu S; Wu Z; Zheng S
Eur J Cardiothorac Surg; 2009 Sep; 36(3):460-4. PubMed ID: 19502078
[TBL] [Abstract][Full Text] [Related]
17. Advantages of assaying telomerase activity in ascites for diagnosis of digestive tract malignancies.
Li CP; Huang TS; Chao Y; Chang FY; Whang-Peng J; Lee SD
World J Gastroenterol; 2004 Sep; 10(17):2468-71. PubMed ID: 15300886
[TBL] [Abstract][Full Text] [Related]
18. Peritoneal cytology as an indicator of disease in patients with residual ovarian carcinoma.
Rubin SC; Dulaney ED; Markman M; Hoskins WJ; Saigo PE; Lewis JL
Obstet Gynecol; 1988 Jun; 71(6 Pt 1):851-3. PubMed ID: 3285264
[TBL] [Abstract][Full Text] [Related]
19. Telomerase detection in body fluids.
Hess JL; Highsmith WE
Clin Chem; 2002 Jan; 48(1):18-24. PubMed ID: 11751534
[TBL] [Abstract][Full Text] [Related]
20. Analysis of telomerase activity in ovarian cystadenomas, low-malignant-potential tumors, and invasive carcinomas.
Datar RH; Naritoku WY; Li P; Tsao-Wei D; Groshen S; Taylor CR; Imam SA
Gynecol Oncol; 1999 Sep; 74(3):338-45. PubMed ID: 10479490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
